AMEX · Medical - Pharmaceuticals

Nasus Pharma Ltd. (NSRX) Stock

$3.32 -5.14% AMEX: NSRX Healthcare

Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats.

Valuation

MetricValue
Price$3.32
Market Cap$28.59M
P/E Ratio-19.53
P/B Ratio0.00
P/S Ratio0.00
EPS (TTM)$-0.17
52-Week High$9.99
52-Week Low$1.98
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE0.00%
ROA0.00%
ROCE0.00%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio0.00

Annual Financials (USD)

Metric202220232024
Revenue$0$0$0
Operating Profit$-2.0M$-1.0M$-1.0M
Net Profit$-2.0M$-1.0M$-2.0M
EPS$-0.19$-0.12$-0.17
Op Margin———

Balance Sheet (USD)

Metric202220232024
Total Assets———
Total Liabilities———
Cash———
Borrowings$0$0$0

Latest News

OTC Markets Life Sciences Investor Forum: Dan Teleman, CEO, and Eyal Rubin, SVP and CFO, of Nasus Pharma with Zacks SCR's John Vandermosten, CFA Zacks Small Cap Research · Jul 7, 2026 Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing GlobeNewswire · Jun 26, 2026 Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th GlobeNewswire · Jun 23, 2026 NSRX: NS002 June KOL Event Zacks Small Cap Research · Jun 22, 2026 Nasus Pharma to Participate in the Zacks Life Sciences Investor Forum GlobeNewswire · Jun 22, 2026

Cash Flow (USD)

Metric202220232024
Operating Cash Flow———
Investing Cash Flow———
Financing Cash Flow———
Net Cash Flow———
Free Cash Flow$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio-0.20
EV / EBITDA-18.94
FCF Yield0.00%
Quick Ratio0.00
Interest Coverage-37.17
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held49.17%
Institutions Held18.57%
Institutions Float Held36.52%
Institutional HolderSharesReport Date
Balyasny Asset Management LP898,4732026-03-31
Cable Car Capital, LP601,9982026-03-31
Velan Capital Investment Management LP359,3902026-03-31
Hudson Bay Capital Management Lp134,7712026-03-31
Bleichroeder LP89,8482026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACET $8.30 +1.22% -0.46 $77.59M 0.00%
ACRV $1.73 +2.37% -0.95 $74.05M 0.00%
ADAGAdagene Inc. $3.67 +1.66% -7.78 $138.17M 0.00%
CRVO $2.56 -3.76% -1.09 $23.70M 0.00%
FBIO $2.67 -3.61% 0.91 $88.69M 0.00%

About Nasus Pharma Ltd.

Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats. The company's products include NS002, Intranasal Epinephrine for assisting in severe allergic reaction emergency situations and NS001, an Intranasal Naloxone powder nasal spray for the treatment of opioid overdose. Nasus Pharma Ltd. was incorporated in 2019 and is based in Tel Aviv-Yafo, Israel.

Nasus Pharma Ltd. is led by CEO Dan Teleman, employs 2 people, headquartered in IL, publicly traded since 2025.

Nasus Pharma Ltd. (NSRX) stock trades at $3.32 with a market capitalization of $28.59M. The stock is valued at a price-to-earnings (P/E) ratio of -19.53, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.98 and $9.99, and currently trades 66.8% below its 52-week high.

On profitability, Nasus Pharma Ltd. generates a return on equity (ROE) of 0.00%, return on capital employed of 0.00%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.nasuspharma.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides